Explore the vast range of titles available.

Background The ideal level of ligation of the inferior mesenteric artery (IMA) during curative resection of sigmoid colon and rectal cancer is still controversial. The aim of this meta-analysis was to examine the impact of high ligation and low ligation of the IMA on anastomotic leakage, overall morbidity, postoperative mortality, and oncological outcomes in patients undergoing surgery for sigmoid colon and rectal cancer. Methods PubMed, EMBASE, Web of Science, and BioMed Central databases were searched to identify relevant articles published from May 1953 to March 2018. A total of 18 articles (14 non-randomized studies and 4 randomized clinical trials) were identified. Review Manager 5.3 software was used for analysis of data. The pooled odds ratio (OR) and weighted mean difference (WMD), with 95% CI, were calculated using either the fixed effects model or random effects model. Results Of the 5917 patients included in this meta-analysis, 3652 patients underwent low ligation of the IMA and 2265 patients underwent high ligation of the IMA. Anastomotic leakage rate was 9.8% in high ligation patients vs. 7.0% in low ligation patients; the risk of anastomotic leakage was significantly higher in high ligation patients (OR = 1.33; 95% CI 1.10–1.62; P  = 0.004). What is more, overall morbidity was also significantly higher in high ligation patients (OR = 1.39; 95% CI, 1.05–1.68; P  = 0.05). Postoperative mortality, number of harvested lymph nodes, overall recurrence rate, and 5-year survival rate did not differ significantly between the two groups. Conclusion Low ligation of the IMA during curative resection of sigmoid colon and rectal cancer appears to be associated with lower risk of anastomotic leakage and overall morbidity. However, there was no significant advantage of low ligation over high ligation of IMA in terms of postoperative mortality, the number of harvested lymph nodes, overall recurrence rate, or 5-year survival rate.

Background In this systematic review and meta-analysis, we aimed to determine the risk factors associated with neck hematoma requiring surgical re-intervention after thyroidectomy. Methods We systematically searched all articles available in the literature published in PubMed and CNKI databases through May 30, 2017. The quality of these articles was assessed using the Newcastle-Ottawa Quality Assessment Scale, and data were extracted for classification and analysis by focusing on articles related with neck hematoma requiring surgical re-intervention after thyroidectomy. Our meta-analysis was performed according to the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines. Results Of the 1028 screened articles, 26 met the inclusion criteria and were finally analyzed. The factors associated with a high risk of neck hematoma requiring surgical re-intervention after thyroidectomy included male gender (odds ratio [OR]: 1.86, 95% confidence interval [CI]: 1.60–2.17, P  < 0.00001), age (MD: 4.92, 95% CI: 4.28–5.56, P  < 0.00001), Graves disease (OR: 1.81, 95% CI: 1.60–2.05, P  < 0.00001), hypertension (OR: 2.27, 95% CI: 1.43–3.60, P  = 0.0005), antithrombotic drug use (OR: 1.92, 95% CI: 1.51–2.44, P  < 0.00001), thyroid procedure in low-volume hospitals (OR: 1.32, 95% CI: 1.12–1.57, P  = 0.001), prior thyroid surgery (OR: 1.93, 95% CI: 1.11–3.37, P  = 0.02), bilateral thyroidectomy (OR: 1.19, 95% CI: 1.09–1.30, P  < 0.0001), and neck dissection (OR: 1.55, 95% CI: 1.23–1.94, P  = 0.0002). Smoking status (OR: 1.19, 95% CI: 0.99–1.42, P  = 0.06), malignant tumors (OR: 1.00, 95% CI: 0.83–1.20, P  = 0.97), and drainage used (OR: 2.02, 95% CI: 0.69–5.89, P  = 0.20) were not significantly associated with postoperative neck hematoma. Conclusion: We identified certain risk factors for neck hematoma requiring surgical re-intervention after thyroidectomy, including male gender, age, Graves disease, hypertension, antithrombotic agent use, history of thyroid procedures in low-volume hospitals, previous thyroid surgery, bilateral thyroidectomy, and neck dissection. Appropriate intervention measures based on these risk factors may reduce the incidence of postoperative hematoma and yield greater benefits for the patients.

This study evaluated the effects of dietary calcium (Ca) and crude protein (CP) levels on growth performance, nutrient utilization, intestinal morphology, and digestive enzyme activities in goslings during the brooding period. A total of 972 one-day-old Jiangnan White goslings were assigned to a 3 × 3 factorial design with three levels of Ca (0.32%, 0.96%, and 2.88%) and three levels of CP (14.5%, 18.5%, and 22.5%). Results showed that moderate Ca (0.96%) and CP (14.5–18.5%) levels optimized growth performance, with higher body weight (BW), average daily gain (ADG), and average daily feed intake (ADFI), while excessive Ca (2.88%) impaired growth and the feed conversion ratio (FCR). Intestinal morphology was enhanced by 0.96% Ca and moderate CP levels, as reflected by greater villus height and crypt depth. Digestive enzyme activities in the duodenum, jejunum, and ileum were significantly influenced by dietary treatments, with moderate nutrient levels supporting optimal enzymatic efficiency. Nutrient utilization analyses revealed that Ca and CP levels interacted to optimize calcium, phosphorus, and protein metabolism, with the highest utilization rates observed at 0.96% Ca and 14.5% CP. These findings emphasize the importance of balanced dietary formulations to enhance growth performance, nutrient absorption, and metabolic efficiency in goslings, providing practical insights for improving poultry production.

Addressing lateral-directional control challenges during unmanned aerial vehicle (UAV) landing in complex wind fields, this study proposes a drift angle control strategy that integrates coordinated heading and trajectory regulation. An adaptive radius optimization method for the Dubins approach path is designed using wind speed estimation. By developing a wind-coupled flight dynamics model, we establish a roll angle control loop combining the L1 nonlinear guidance law with Linear Active Disturbance Rejection Control (LADRC). Simulation tests against conventional sideslip approach and crab approach, along with flight tests, confirm that the proposed autonomous landing system achieves smoother attitude transitions during landing while meeting all touchdown performance requirements. This solution provides a theoretically rigorous and practically viable approach for safe UAV landings in challenging wind conditions.

Radiotherapy combined with immune checkpoint blockade holds great promise for synergistic antitumor efficacy. Targeted radionuclide therapy delivers radiation directly to tumor sites. LNC1004 is a fibroblast activation protein (FAP)-targeting radiopharmaceutical, conjugated with the albumin binder Evans Blue, which has demonstrated enhanced tumor uptake and retention in previous preclinical and clinical studies. Herein, we demonstrate that 68 Ga/ 177 Lu-labeled LNC1004 exhibits increased uptake and prolonged retention in MC38/NIH3T3-FAP and CT26/NIH3T3-FAP tumor xenografts. Radionuclide therapy with 177 Lu-LNC1004 induced a transient upregulation of PD-L1 expression in tumor cells. The combination of 177 Lu-LNC1004 and anti-PD-L1 immunotherapy led to complete eradication of all tumors in MC38/NIH3T3-FAP tumor-bearing mice, with mice showing 100% tumor rejection upon rechallenge. Immunohistochemistry, single-cell RNA sequencing (scRNA-seq), and TCR sequencing revealed that combination therapy reprogrammed the tumor microenvironment in mice to foster antitumor immunity by suppressing malignant progression and increasing cell-to-cell communication, CD8 + T-cell activation and expansion, M1 macrophage counts, antitumor activity of neutrophils, and T-cell receptor diversity. A preliminary clinical study demonstrated that 177 Lu-LNC1004 was well-tolerated and effective in patients with refractory cancers. Further, scRNA-seq of peripheral blood mononuclear cells underscored the importance of addressing immune evasion through immune checkpoint blockade treatment. This was emphasized by the observed increase in antigen processing and presentation juxtaposed with T cell inactivation. In conclusion, our data supported the efficacy of immunotherapy combined with 177 Lu-LNC1004 for cancer patients with FAP-positive tumors.

Traditional total mesorectal excision (TME) for rectal cancer requires partial resection of Denonvilliers’ fascia (DVF), which leads to injury of pelvic autonomic nerve and postoperative urogenital dysfunction. It is still unclear whether entire preservation of DVF has better urogenital function and comparable oncological outcomes. We conducted a randomized clinical trial to investigate the superiority of DVF preservation over resection (NCT02435758). A total of 262 eligible male patients were randomized to Laparoscopic TME with DVF preservation (L-DVF-P group) or resection procedures (L-DVF-R group), 242 of which completed the study, including 122 cases of L-DVF-P and 120 cases of L-DVF-R. The initial analysis of the primary outcomes of urogenital function has previously been reported. Here, the updated analysis and secondary outcomes including 3-year survival (OS), 3-year disease-free survival (DFS), and recurrence rate between the two groups are reported for the modified intention-to-treat analysis, revealing no significant difference. In conclusion, L-DVF-P reveals better postoperative urogenital function and comparable oncological outcomes for male rectal cancer patients. Total mesorectal excision (TME) for rectal cancer can require partial resection of Denonvilliers’ fascia (DVF). Here the authors report the secondary outcomes of a randomized trial to evaluate the safety and effect of DVF preservation during laparoscopic TME on postoperative urogenital function and oncological safety in male patients with mid-low rectal cancer.

Ripening agents can accelerate the ripening of fruits and maintain a similar appearance to naturally ripe fruits, but the fruit flavor and quality will be changed compared to naturally ripe fruits. To find an efficient detection method to distinguish whether crab apples were artificial ripened, the naturally ripe and artificially ripe fruits were detected and analyzed using the electronic nose (e-nose) technique in this study. The fruit quality indexes of samples were determined by the traditional method as a reference. Significant differences were found between naturally ripe and artificially ripe fruits based on the analysis of soluble sugar content, titratable acidity content, sugar–acid ratio, soluble protein content, and soluble solids content. In addition, principal component analysis (PCA), linear discriminant analysis (LDA), support vector machine (SVM), and random forest (RF) analyses were performed on the electrical signals generated by the electronic nose sensor, respectively. The results showed that the RF is the best recognition algorithm for distinguishing which crab apples were naturally ripe or artificially ripe; the average recognition accuracy is 98.3%. On the other hand, the prediction models between the e-nose response data and fruit quality indexes were constructed by partial least squares regression (PLSR), which showed that the feature value of e-nose response curves extracted by wavelet transform was highly correlated with the quality indexes of fruits, the determination coefficients (R2) of regression models were higher than 0.91. The results demonstrated that the detection technology with an electronic nose could be used to test whether the fruit of the crab apple was artificially ripe, which is an economical and efficient method.

The swelling agent is a plant growth regulator that alters the composition and content of nutrients and volatile gases in the fruit. To identify whether grape fruit had been treated with swelling agent, the odor information and quality indexes of grape berries treated with different concentrations of swelling agent were examined by using electronic nose technology and traditional methods. The contents of soluble sugars, soluble solids, soluble proteins and vitamin C were significantly increased in N-(2-chloro-4-pyridyl)-N’-phenylurea (CPPU) treated fruit. The contents of hexanal, (E)-2-hexenal, and nonanal aldehydes decreased significantly. Similarly, the levels of phenyl ethanol, 1-octanol, ethanol, and ethyl acetate alcohols and esters also decreased noticeably. Additionally, the levels of damascenone, linalool, and geraniol ketones and terpenoids decreased. However, the contents of benzaldehyde, D-limonene, acetic acid and hexanoic acid increased. In addition, the electrical signals generated by the electronic nose (e-nose) were analyzed by linear discriminant analysis (LDA), support vector machine (SVM) and random forest (RF). The average recognition rate of SVM was 94.4%. The results showed that electronic nose technology can be used to detect whether grapes have been treated with swelling agent, and it is an economical and efficient detection method.

Dietary protein plays a crucial role in poultry nutrition, influencing nitrogen metabolism, renal function, and immune responses. This study investigated the effects of dietary protein source (plant-based vs. animal-based) and level (14.5, 18.5, and 22.5%) on serum biochemical parameters, renal metabolic markers, inflammatory cytokines, and gene expression in Jiangnan White goslings from day 1 to day 30 of age. A 2 × 3 factorial design was employed with 504 goslings randomly assigned to six groups, each comprising six replicates with 14 goslings per replicate. The results showed that dietary protein level significantly influenced serum uric acid (UA), creatinine (Cr), urea nitrogen (UN), and xanthine oxidase (XOD) activity, with goslings fed a high-protein diet (22.5%) exhibiting the highest levels ( p  < 0.05). Increased dietary protein also led to significantly elevated renal UA concentrations and XOD activity, particularly at 22 and 30 days ( p  < 0.05). In contrast, dietary protein source had limited influence on metabolic parameters, with only a transient difference in serum UA and Cr observed at 10 days of age ( p  < 0.05), and no significant effects on other serum or renal markers ( p  > 0.05). Additionally, renal inflammatory cytokines (IL-1 β , IL-8, TNF-β) were significantly influenced by protein level, whereas XDH, BCL-2, and GLUT-9 mRNA expression remained unchanged ( p  > 0.05). No significant interactions between protein source and level were observed for most metabolic parameters, except for Cr and TNF- β . These findings suggest that total protein intake, rather than protein source, is the primary regulator of nitrogen metabolism and renal health in goslings. Optimization of protein levels is essential to balance growth performance and metabolic homeostasis.

BackgroundFibroblast activation protein (FAP)-targeted radioligand therapy, with immunomodulatory effects, has shown efficacy in both preclinical and clinical studies. We recently reported on a novel dimeric FAP-targeting radiopharmaceutical, 68Ga/177Lu-DOTA-2P(FAPI)2, which demonstrated increased tumor uptake and prolonged retention in various cancers. However, further exploration is required to understand the therapeutic efficacy and underlying mechanisms of combining 68Ga/177Lu-DOTA-2P(FAPI)2 radioligand therapy with PD-1/PD-L1 immunotherapy.MethodsRegarding the change in PD-L1 expression and DNA double-strand breaks induced by radiopharmaceuticals, CT26-FAP tumor cells were incubated with 68Ga and 177Lu labeled DOTA-2P(FAPI)2, respectively. Monotherapy with 68Ga-DOTA-2P(FAPI)2, 177Lu-DOTA-2P(FAPI)2, and PD-L1 immunotherapy as well as combination therapy (68Ga/177Lu-DOTA-2P(FAPI)2 and PD-L1 immunotherapy) were tested and evaluated to evaluate in vivo antitumor efficacy. Furthermore, immunohistochemical staining and single-cell RNA sequencing were used to analyze changes in the tumor microenvironment (TME) and elucidate the underlying mechanisms of action of this combination therapy.ResultsOur findings indicated that FAP-targeting radiopharmaceuticals can induce DNA double-strand breaks and upregulate PD-L1 expression, with 177Lu-DOTA-2P(FAPI)2 proving to be more effective than 68Ga-DOTA-2P(FAPI)2. Both 68Ga-DOTA-2P(FAPI)2 and 177Lu-DOTA-2P(FAPI)2 radiopharmaceuticals significantly improved therapeutic outcomes when combined with anti-PD-L1 monoclonal antibody (αPD-L1 mAb). Notably, the combination of 177Lu-DOTA-2P(FAPI)2 with αPD-L1 mAb immunotherapy eliminated tumors in mouse models. Mice treated with this regimen not only exhibited exceptional responses to the initial immune checkpoint inhibitor therapy but also showed 100% tumor rejection on subsequent tumor cell re-inoculation. Further mechanistic studies have shown that 177Lu-DOTA-2P(FAPI)2 combined with αPD-L1 mAb can reprogram the TME, enhancing antitumor intercellular communication, which activates antitumor-related intercellular contacts such as FasL-Fas interactions between T cells and NK cells with tumor cells and increasing the proportion of infiltrating CD8+ T-cells while reducing regulatory T cells and inhibiting tumor progression. Our research also demonstrates that mature neutrophils play a role in enhancing the efficacy of the combined therapy, as shown in neutrophil-blocking experiments.ConclusionsOur study robustly advocates for use of FAP-targeting radiopharmaceuticals, particularly 177Lu-DOTA-2P(FAPI)2, alongside immunotherapy in treating FAP-positive tumors. This combination therapy transforms the TME and enables a translatable approach to increasing the sensitivity to PD-1/PD-L1 immunotherapy, leading to improved complete remission rates and extended overall survival.